Cite
HARVARD Citation
Wolinsky, J. et al. (2017). Evaluation of no evidence of progression or active disease (nepad) in patients with primary progressive multiple sclerosis in the oratorio trial. Journal of neurology, neurosurgery and psychiatry. 88 (5), p. e1. [Online].